

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 8.33855483 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 8.33855483 |
| 3 | detection of temperature stimulus (GO:0016048) | 8.33269441 |
| 4 | neurofilament cytoskeleton organization (GO:0060052) | 7.91807762 |
| 5 | neuronal action potential (GO:0019228) | 6.65358095 |
| 6 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.55611996 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 6.38728590 |
| 8 | central nervous system myelination (GO:0022010) | 6.38728590 |
| 9 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.97834301 |
| 10 | peripheral nervous system neuron development (GO:0048935) | 5.80739644 |
| 11 | response to pain (GO:0048265) | 5.48367785 |
| 12 | cell migration in hindbrain (GO:0021535) | 5.12388085 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 5.11097777 |
| 14 | postsynaptic membrane organization (GO:0001941) | 5.08075640 |
| 15 | behavioral response to pain (GO:0048266) | 5.04260786 |
| 16 | membrane depolarization during action potential (GO:0086010) | 4.95663520 |
| 17 | urinary tract smooth muscle contraction (GO:0014848) | 4.91821243 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.81419786 |
| 19 | L-amino acid import (GO:0043092) | 4.70530282 |
| 20 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.69384498 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.65306654 |
| 22 | sodium ion export (GO:0071436) | 4.61820535 |
| 23 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.57624608 |
| 24 | one-carbon compound transport (GO:0019755) | 4.55130222 |
| 25 | proline transport (GO:0015824) | 4.52391692 |
| 26 | presynaptic membrane assembly (GO:0097105) | 4.51578944 |
| 27 | enteric nervous system development (GO:0048484) | 4.48252217 |
| 28 | response to water (GO:0009415) | 4.45953281 |
| 29 | presynaptic membrane organization (GO:0097090) | 4.38975580 |
| 30 | negative regulation of dendrite development (GO:2000171) | 4.29970485 |
| 31 | hyperosmotic salinity response (GO:0042538) | 4.22513534 |
| 32 | astrocyte differentiation (GO:0048708) | 4.21084988 |
| 33 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.19822301 |
| 34 | potassium ion import (GO:0010107) | 4.18512078 |
| 35 | negative regulation of microtubule polymerization (GO:0031115) | 4.17946307 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.15393057 |
| 37 | neuronal ion channel clustering (GO:0045161) | 4.10593191 |
| 38 | potassium ion homeostasis (GO:0055075) | 4.10230587 |
| 39 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 4.09016381 |
| 40 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.01543743 |
| 41 | amino acid import (GO:0043090) | 3.99714071 |
| 42 | cell communication involved in cardiac conduction (GO:0086065) | 3.92908126 |
| 43 | action potential (GO:0001508) | 3.92738909 |
| 44 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.92657124 |
| 45 | cellular sodium ion homeostasis (GO:0006883) | 3.91824605 |
| 46 | sympathetic nervous system development (GO:0048485) | 3.91769990 |
| 47 | cellular response to nicotine (GO:0071316) | 3.91387483 |
| 48 | regulation of platelet aggregation (GO:0090330) | 3.88274133 |
| 49 | neurotransmitter uptake (GO:0001504) | 3.84357258 |
| 50 | adenosine metabolic process (GO:0046085) | 3.81512631 |
| 51 | neuronal action potential propagation (GO:0019227) | 3.80022835 |
| 52 | cerebellar granule cell differentiation (GO:0021707) | 3.77913806 |
| 53 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.74585227 |
| 54 | neuromuscular synaptic transmission (GO:0007274) | 3.73363323 |
| 55 | exploration behavior (GO:0035640) | 3.72569370 |
| 56 | behavioral response to nicotine (GO:0035095) | 3.72515992 |
| 57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.70992758 |
| 58 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.69665509 |
| 59 | astrocyte development (GO:0014002) | 3.68005120 |
| 60 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.65879329 |
| 61 | positive regulation of synapse maturation (GO:0090129) | 3.63495516 |
| 62 | axon cargo transport (GO:0008088) | 3.62006471 |
| 63 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.60342125 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.59436161 |
| 65 | potassium ion export (GO:0071435) | 3.59003589 |
| 66 | establishment of mitochondrion localization (GO:0051654) | 3.57609976 |
| 67 | retinal ganglion cell axon guidance (GO:0031290) | 3.56247829 |
| 68 | neurotransmitter secretion (GO:0007269) | 3.49625916 |
| 69 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.48864893 |
| 70 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.46334189 |
| 71 | positive regulation of muscle hypertrophy (GO:0014742) | 3.46334189 |
| 72 | negative regulation of complement activation (GO:0045916) | 3.42140012 |
| 73 | dopamine biosynthetic process (GO:0042416) | 3.38479349 |
| 74 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.29624421 |
| 75 | peristalsis (GO:0030432) | 3.28125479 |
| 76 | positive regulation of neurological system process (GO:0031646) | 3.26225382 |
| 77 | myelination (GO:0042552) | 3.25919846 |
| 78 | intermediate filament organization (GO:0045109) | 3.25883651 |
| 79 | regulation of neurotransmitter levels (GO:0001505) | 3.23442315 |
| 80 | ensheathment of neurons (GO:0007272) | 3.21963133 |
| 81 | axon ensheathment (GO:0008366) | 3.21963133 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.21540650 |
| 83 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.20267369 |
| 84 | mitochondrion transport along microtubule (GO:0047497) | 3.20267369 |
| 85 | vocalization behavior (GO:0071625) | 3.19263524 |
| 86 | neurotransmitter transport (GO:0006836) | 3.17479660 |
| 87 | cell communication by electrical coupling (GO:0010644) | 3.16497666 |
| 88 | multicellular organismal response to stress (GO:0033555) | 3.13481745 |
| 89 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.12638277 |
| 90 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.12407893 |
| 91 | long-term synaptic potentiation (GO:0060291) | 3.11926993 |
| 92 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.11605909 |
| 93 | acrosome reaction (GO:0007340) | 3.11577488 |
| 94 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.10921615 |
| 95 | synaptic vesicle endocytosis (GO:0048488) | 3.10382331 |
| 96 | synaptic transmission, glutamatergic (GO:0035249) | 3.09040310 |
| 97 | intermediate filament-based process (GO:0045103) | 3.08287108 |
| 98 | negative regulation of neurotransmitter transport (GO:0051589) | 3.07320118 |
| 99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.07319399 |
| 100 | regulation of cell communication by electrical coupling (GO:0010649) | 3.06779395 |
| 101 | glutamate secretion (GO:0014047) | 3.06675464 |
| 102 | behavioral response to ethanol (GO:0048149) | 3.06522354 |
| 103 | membrane repolarization (GO:0086009) | 3.05184579 |
| 104 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04596934 |
| 105 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.04235768 |
| 106 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.03991631 |
| 107 | neuron cell-cell adhesion (GO:0007158) | 3.03191520 |
| 108 | intermediate filament cytoskeleton organization (GO:0045104) | 3.03029151 |
| 109 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.02604314 |
| 110 | glutamate receptor signaling pathway (GO:0007215) | 3.01393166 |
| 111 | gamma-aminobutyric acid transport (GO:0015812) | 3.01015314 |
| 112 | regulation of synapse maturation (GO:0090128) | 3.00070561 |
| 113 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.99617263 |
| 114 | axon development (GO:0061564) | 2.98942545 |
| 115 | auditory behavior (GO:0031223) | 2.97486540 |
| 116 | positive regulation of potassium ion transport (GO:0043268) | 2.97229088 |
| 117 | innervation (GO:0060384) | 2.96346052 |
| 118 | sodium ion transmembrane transport (GO:0035725) | 2.96327240 |
| 119 | acidic amino acid transport (GO:0015800) | 2.96252166 |
| 120 | negative regulation of inclusion body assembly (GO:0090084) | 2.95521106 |
| 121 | response to methylmercury (GO:0051597) | 2.94444347 |
| 122 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93525429 |
| 123 | regulation of neurotransmitter uptake (GO:0051580) | 2.93392118 |
| 124 | synaptic vesicle maturation (GO:0016188) | 2.93333723 |
| 125 | myelin maintenance (GO:0043217) | 2.92942072 |
| 126 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.92740623 |
| 127 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.91372332 |
| 128 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.90829295 |
| 129 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.90474810 |
| 130 | neuromuscular process controlling balance (GO:0050885) | 2.89601780 |
| 131 | activation of protein kinase A activity (GO:0034199) | 2.89217601 |
| 132 | regulation of neurotransmitter transport (GO:0051588) | 2.88160710 |
| 133 | endothelial cell chemotaxis (GO:0035767) | 2.88153669 |
| 134 | plasma membrane repair (GO:0001778) | 2.87564230 |
| 135 | nerve growth factor signaling pathway (GO:0038180) | 2.86967703 |
| 136 | response to ATP (GO:0033198) | 2.86853358 |
| 137 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.86747976 |
| 138 | sensory perception of pain (GO:0019233) | 2.86652241 |
| 139 | cranial nerve development (GO:0021545) | 2.86020732 |
| 140 | response to acidic pH (GO:0010447) | 2.84573766 |
| 141 | phenol-containing compound catabolic process (GO:0019336) | 2.84343328 |
| 142 | calcium ion-dependent exocytosis (GO:0017156) | 2.84248530 |
| 143 | regulation of ARF protein signal transduction (GO:0032012) | 2.82521169 |
| 144 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.81626534 |
| 145 | membrane budding (GO:0006900) | 2.80180524 |
| 146 | organelle transport along microtubule (GO:0072384) | 2.79870858 |
| 147 | alanine transport (GO:0032328) | 2.79819117 |
| 148 | neuron fate specification (GO:0048665) | 2.79480303 |
| 149 | neurotransmitter catabolic process (GO:0042135) | 2.78976003 |
| 150 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78964482 |
| 151 | negative regulation of cation channel activity (GO:2001258) | 2.78232463 |
| 152 | neuron-neuron synaptic transmission (GO:0007270) | 2.78051448 |
| 153 | layer formation in cerebral cortex (GO:0021819) | 2.77816313 |
| 154 | regulation of respiratory system process (GO:0044065) | 2.76646037 |
| 155 | synaptic vesicle exocytosis (GO:0016079) | 2.76445181 |
| 156 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.76358365 |
| 157 | adult walking behavior (GO:0007628) | 2.76312764 |
| 158 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.76035927 |
| 159 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.75267230 |
| 160 | regulation of sensory perception (GO:0051931) | 2.74827561 |
| 161 | regulation of sensory perception of pain (GO:0051930) | 2.74827561 |
| 162 | regulation of synapse structural plasticity (GO:0051823) | 2.74220114 |
| 163 | regulation of neurotransmitter secretion (GO:0046928) | 2.73393223 |
| 164 | startle response (GO:0001964) | 2.73346435 |
| 165 | transmission of nerve impulse (GO:0019226) | 2.73133239 |
| 166 | axonal fasciculation (GO:0007413) | 2.72571852 |
| 167 | myelination in peripheral nervous system (GO:0022011) | 2.72406822 |
| 168 | peripheral nervous system axon ensheathment (GO:0032292) | 2.72406822 |
| 169 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.72210001 |
| 170 | L-glutamate transport (GO:0015813) | 2.71172797 |
| 171 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.70943133 |
| 172 | regulation of axon regeneration (GO:0048679) | 2.70036327 |
| 173 | regulation of neuron projection regeneration (GO:0070570) | 2.70036327 |
| 174 | positive regulation of membrane potential (GO:0045838) | 2.69043444 |
| 175 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68882480 |
| 176 | protein localization to synapse (GO:0035418) | 2.68617719 |
| 177 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.67671619 |
| 178 | neuron projection regeneration (GO:0031102) | 2.67020314 |
| 179 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.66852347 |
| 180 | vesicle transport along microtubule (GO:0047496) | 2.65391136 |
| 181 | regulation of synaptic vesicle transport (GO:1902803) | 2.65137800 |
| 182 | negative regulation of protein activation cascade (GO:2000258) | 2.64945122 |
| 183 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.64531093 |
| 184 | regulation of cell maturation (GO:1903429) | 2.64500035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.85909102 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.07659683 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03840373 |
| 4 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79366386 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76677258 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71897116 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.71484102 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55430547 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52625439 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52625439 |
| 11 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.49474326 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.49200702 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41755727 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41194441 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36898222 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35124083 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.33885836 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.30714278 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25143240 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21601729 |
| 21 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.10602622 |
| 22 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.92773527 |
| 23 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.89316851 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85881972 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82836377 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78686016 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78595014 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78354481 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77264318 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73954023 |
| 31 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.66896466 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60536193 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60433694 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59957968 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59832810 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57238235 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57130120 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.56497308 |
| 39 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.56204067 |
| 40 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51671701 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.51066677 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46528723 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46430459 |
| 44 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.46253046 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40730430 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39826798 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38447805 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37980298 |
| 49 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37216353 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37195272 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36536821 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35986952 |
| 53 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35898002 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35691703 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34053501 |
| 56 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.33274418 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32077398 |
| 58 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.31244440 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28238928 |
| 60 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.28040611 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24786115 |
| 62 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24717140 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22318496 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22289078 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21876317 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21724106 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21570786 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20478989 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18043444 |
| 70 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17376827 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17276007 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16968669 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16027742 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14765068 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14027336 |
| 76 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13203363 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.13153060 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11783912 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11119892 |
| 80 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.11063002 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10802077 |
| 82 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.10405844 |
| 83 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09730356 |
| 84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09452586 |
| 85 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08231711 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06937556 |
| 87 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06764656 |
| 88 | JUN_21703547_ChIP-Seq_K562_Human | 1.06704765 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05335587 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03775553 |
| 91 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03535538 |
| 92 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03442045 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03400352 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03070671 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03052734 |
| 96 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03052734 |
| 97 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02498063 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01636353 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01500092 |
| 100 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99533066 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99311036 |
| 102 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98357635 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97065314 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97065314 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96026755 |
| 106 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95908841 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95765755 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95362654 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94930142 |
| 110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94851705 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94837336 |
| 112 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94183696 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94172293 |
| 114 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93859895 |
| 115 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93115145 |
| 116 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92940016 |
| 117 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92928217 |
| 118 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.91418140 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91233756 |
| 120 | AR_19668381_ChIP-Seq_PC3_Human | 0.90686066 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90117662 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89583082 |
| 123 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87913298 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87794324 |
| 125 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87738212 |
| 126 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87305477 |
| 127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87121432 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86154934 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85443499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 7.06786222 |
| 2 | MP0002736_abnormal_nociception_after | 6.54773374 |
| 3 | * MP0002735_abnormal_chemical_nociception | 6.48834842 |
| 4 | MP0001986_abnormal_taste_sensitivity | 4.75466690 |
| 5 | MP0004270_analgesia | 4.64017720 |
| 6 | MP0004858_abnormal_nervous_system | 4.38891178 |
| 7 | MP0002734_abnormal_mechanical_nocicepti | 4.22589874 |
| 8 | * MP0002733_abnormal_thermal_nociception | 4.05040366 |
| 9 | MP0003690_abnormal_glial_cell | 3.85251516 |
| 10 | * MP0001970_abnormal_pain_threshold | 3.55676543 |
| 11 | * MP0006276_abnormal_autonomic_nervous | 3.37127017 |
| 12 | MP0004885_abnormal_endolymph | 2.78238352 |
| 13 | MP0002751_abnormal_autonomic_nervous | 2.50610368 |
| 14 | MP0002272_abnormal_nervous_system | 2.35220431 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.19848090 |
| 16 | MP0002184_abnormal_innervation | 2.16391914 |
| 17 | MP0002067_abnormal_sensory_capabilities | 2.15703912 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 2.14476020 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.00989510 |
| 20 | MP0000569_abnormal_digit_pigmentation | 1.95519129 |
| 21 | MP0002822_catalepsy | 1.90441290 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.87853142 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.83550230 |
| 24 | MP0003283_abnormal_digestive_organ | 1.71535716 |
| 25 | MP0001502_abnormal_circadian_rhythm | 1.71180634 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.71151800 |
| 27 | MP0003880_abnormal_central_pattern | 1.63061821 |
| 28 | MP0001984_abnormal_olfaction | 1.57922915 |
| 29 | MP0009745_abnormal_behavioral_response | 1.56977352 |
| 30 | MP0000566_synostosis | 1.56448226 |
| 31 | MP0009046_muscle_twitch | 1.55734483 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.51296487 |
| 33 | MP0008260_abnormal_autophagy | 1.44639806 |
| 34 | MP0001958_emphysema | 1.43755921 |
| 35 | MP0001348_abnormal_lacrimal_gland | 1.40801480 |
| 36 | MP0000955_abnormal_spinal_cord | 1.39226499 |
| 37 | MP0001177_atelectasis | 1.39075602 |
| 38 | MP0001270_distended_abdomen | 1.35856485 |
| 39 | MP0002064_seizures | 1.35647367 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.32550624 |
| 41 | MP0002063_abnormal_learning/memory/cond | 1.31947174 |
| 42 | MP0000538_abnormal_urinary_bladder | 1.30975920 |
| 43 | * MP0004811_abnormal_neuron_physiology | 1.29509284 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.27962890 |
| 45 | MP0003329_amyloid_beta_deposits | 1.24473028 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.22550990 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.20612217 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.17162442 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.15894508 |
| 50 | MP0004147_increased_porphyrin_level | 1.13881447 |
| 51 | MP0002653_abnormal_ependyma_morphology | 1.13044205 |
| 52 | MP0000778_abnormal_nervous_system | 1.12746904 |
| 53 | MP0001905_abnormal_dopamine_level | 1.11517877 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.10779267 |
| 55 | MP0002152_abnormal_brain_morphology | 1.09359687 |
| 56 | MP0000749_muscle_degeneration | 1.07890500 |
| 57 | MP0001188_hyperpigmentation | 1.07392999 |
| 58 | MP0003633_abnormal_nervous_system | 1.06778223 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.04213111 |
| 60 | MP0000751_myopathy | 1.03727073 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.00361903 |
| 62 | MP0000026_abnormal_inner_ear | 1.00297318 |
| 63 | MP0004924_abnormal_behavior | 0.94674806 |
| 64 | MP0005386_behavior/neurological_phenoty | 0.94674806 |
| 65 | MP0002229_neurodegeneration | 0.93544569 |
| 66 | MP0002752_abnormal_somatic_nervous | 0.92680043 |
| 67 | MP0004142_abnormal_muscle_tone | 0.87998599 |
| 68 | MP0001299_abnormal_eye_distance/ | 0.87330753 |
| 69 | MP0003136_yellow_coat_color | 0.87036759 |
| 70 | MP0001486_abnormal_startle_reflex | 0.86345181 |
| 71 | MP0003634_abnormal_glial_cell | 0.85814552 |
| 72 | MP0002066_abnormal_motor_capabilities/c | 0.85693426 |
| 73 | MP0008569_lethality_at_weaning | 0.85433258 |
| 74 | MP0005083_abnormal_biliary_tract | 0.84853899 |
| 75 | MP0002557_abnormal_social/conspecific_i | 0.84658622 |
| 76 | MP0003631_nervous_system_phenotype | 0.83898976 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 0.80293200 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 0.79616318 |
| 79 | MP0008874_decreased_physiological_sensi | 0.79172052 |
| 80 | MP0000747_muscle_weakness | 0.76097142 |
| 81 | MP0000920_abnormal_myelination | 0.76072087 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.73933387 |
| 83 | MP0005253_abnormal_eye_physiology | 0.73580897 |
| 84 | MP0005171_absent_coat_pigmentation | 0.73575308 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.73220197 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.73052467 |
| 87 | MP0005670_abnormal_white_adipose | 0.71281856 |
| 88 | MP0004085_abnormal_heartbeat | 0.70846632 |
| 89 | MP0010771_integument_phenotype | 0.70335169 |
| 90 | MP0003878_abnormal_ear_physiology | 0.70130873 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.70130873 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.69539866 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.66937331 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.66667188 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.66085543 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.65598047 |
| 97 | MP0000462_abnormal_digestive_system | 0.65269094 |
| 98 | MP0004742_abnormal_vestibular_system | 0.64235746 |
| 99 | MP0000579_abnormal_nail_morphology | 0.63335858 |
| 100 | MP0003045_fibrosis | 0.63275395 |
| 101 | MP0008872_abnormal_physiological_respon | 0.63042155 |
| 102 | MP0002133_abnormal_respiratory_system | 0.62150778 |
| 103 | MP0005388_respiratory_system_phenotype | 0.62150778 |
| 104 | MP0002972_abnormal_cardiac_muscle | 0.62089244 |
| 105 | MP0009697_abnormal_copulation | 0.61993140 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.61811653 |
| 107 | MP0008775_abnormal_heart_ventricle | 0.60501127 |
| 108 | MP0003861_abnormal_nervous_system | 0.60377446 |
| 109 | MP0003075_altered_response_to | 0.60347868 |
| 110 | MP0004133_heterotaxia | 0.59962555 |
| 111 | MP0001664_abnormal_digestion | 0.59890454 |
| 112 | MP0003122_maternal_imprinting | 0.59722855 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.59558231 |
| 114 | MP0000604_amyloidosis | 0.58432334 |
| 115 | MP0004130_abnormal_muscle_cell | 0.57850330 |
| 116 | MP0003866_abnormal_defecation | 0.57556435 |
| 117 | MP0010769_abnormal_survival | 0.55891023 |
| 118 | MP0005645_abnormal_hypothalamus_physiol | 0.55489892 |
| 119 | MP0004215_abnormal_myocardial_fiber | 0.52476186 |
| 120 | MP0005535_abnormal_body_temperature | 0.52419005 |
| 121 | MP0002160_abnormal_reproductive_system | 0.51928819 |
| 122 | MP0004883_abnormal_blood_vessel | 0.50863042 |
| 123 | MP0001529_abnormal_vocalization | 0.50166791 |
| 124 | MP0000427_abnormal_hair_cycle | 0.48471246 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.45889512 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.44113991 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.44100400 |
| 128 | MP0001542_abnormal_bone_strength | 0.43666871 |
| 129 | MP0003879_abnormal_hair_cell | 0.43350266 |
| 130 | MP0002163_abnormal_gland_morphology | 0.43111940 |
| 131 | MP0005409_darkened_coat_color | 0.42652157 |
| 132 | MP0004484_altered_response_of | 0.41997617 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.39647307 |
| 134 | MP0003137_abnormal_impulse_conducting | 0.38808201 |
| 135 | MP0003632_abnormal_nervous_system | 0.38202411 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.38002815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 9.12605738 |
| 2 | Hypothermia (HP:0002045) | 6.30980160 |
| 3 | Myokymia (HP:0002411) | 6.15919983 |
| 4 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.82844640 |
| 5 | Dysautonomia (HP:0002459) | 5.67050890 |
| 6 | Action tremor (HP:0002345) | 5.53597106 |
| 7 | Termporal pattern (HP:0011008) | 5.41155276 |
| 8 | Insidious onset (HP:0003587) | 5.41155276 |
| 9 | Impaired pain sensation (HP:0007328) | 5.14889047 |
| 10 | Abnormality of pain sensation (HP:0010832) | 5.14889047 |
| 11 | Pheochromocytoma (HP:0002666) | 4.80568153 |
| 12 | Abnormal autonomic nervous system physiology (HP:0012332) | 4.62565936 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 4.46631025 |
| 14 | Abnormality of binocular vision (HP:0011514) | 4.44950510 |
| 15 | Diplopia (HP:0000651) | 4.44950510 |
| 16 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 4.40940367 |
| 17 | Steppage gait (HP:0003376) | 4.35616627 |
| 18 | Foot dorsiflexor weakness (HP:0009027) | 4.19924196 |
| 19 | Hammertoe (HP:0001765) | 3.96242323 |
| 20 | Autoamputation (HP:0001218) | 3.96232759 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.91805313 |
| 22 | Abnormality of the foot musculature (HP:0001436) | 3.75611408 |
| 23 | Genetic anticipation (HP:0003743) | 3.57889482 |
| 24 | Atonic seizures (HP:0010819) | 3.52473192 |
| 25 | Onion bulb formation (HP:0003383) | 3.47514934 |
| 26 | Scanning speech (HP:0002168) | 3.45142120 |
| 27 | Neoplasm of the heart (HP:0100544) | 3.44845826 |
| 28 | Febrile seizures (HP:0002373) | 3.43628506 |
| 29 | Focal seizures (HP:0007359) | 3.40905759 |
| 30 | Postural instability (HP:0002172) | 3.38598633 |
| 31 | Megalencephaly (HP:0001355) | 3.37798086 |
| 32 | Myotonia (HP:0002486) | 3.34672340 |
| 33 | Orthostatic hypotension (HP:0001278) | 3.30625216 |
| 34 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.24903333 |
| 35 | Ankle clonus (HP:0011448) | 3.24004040 |
| 36 | Failure to thrive in infancy (HP:0001531) | 3.21002870 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 3.18370806 |
| 38 | Thyroid carcinoma (HP:0002890) | 3.18361119 |
| 39 | Abnormal eating behavior (HP:0100738) | 3.10726120 |
| 40 | Focal motor seizures (HP:0011153) | 3.09264370 |
| 41 | Arthropathy (HP:0003040) | 3.04625715 |
| 42 | Distal sensory impairment (HP:0002936) | 3.02054053 |
| 43 | Bradycardia (HP:0001662) | 2.98976225 |
| 44 | Aplasia involving bones of the extremities (HP:0009825) | 2.96358522 |
| 45 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.96358522 |
| 46 | Aplasia of the phalanges of the hand (HP:0009802) | 2.96358522 |
| 47 | Alacrima (HP:0000522) | 2.95793785 |
| 48 | Hyporeflexia of lower limbs (HP:0002600) | 2.94435672 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 2.93034612 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.92328254 |
| 51 | Decreased motor nerve conduction velocity (HP:0003431) | 2.86431663 |
| 52 | Abnormality of the vocal cords (HP:0008777) | 2.83231461 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 2.79184707 |
| 54 | Impaired proprioception (HP:0010831) | 2.78073915 |
| 55 | Hemiplegia (HP:0002301) | 2.77601512 |
| 56 | Akinesia (HP:0002304) | 2.75203988 |
| 57 | Hypoventilation (HP:0002791) | 2.70533701 |
| 58 | Hypoplasia of the brainstem (HP:0002365) | 2.69883498 |
| 59 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.69883498 |
| 60 | Dysdiadochokinesis (HP:0002075) | 2.67177850 |
| 61 | Distal arthrogryposis (HP:0005684) | 2.66537383 |
| 62 | Submucous cleft hard palate (HP:0000176) | 2.62096270 |
| 63 | Bundle branch block (HP:0011710) | 2.60665397 |
| 64 | Turricephaly (HP:0000262) | 2.59385064 |
| 65 | Bronchomalacia (HP:0002780) | 2.58767416 |
| 66 | Limb dystonia (HP:0002451) | 2.57388652 |
| 67 | Hemiparesis (HP:0001269) | 2.56238716 |
| 68 | Hypercortisolism (HP:0001578) | 2.54221371 |
| 69 | Recurrent corneal erosions (HP:0000495) | 2.53695889 |
| 70 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.50389050 |
| 71 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.49565804 |
| 72 | Polyphagia (HP:0002591) | 2.49462088 |
| 73 | Increased IgE level (HP:0003212) | 2.47948758 |
| 74 | Areflexia of lower limbs (HP:0002522) | 2.44094156 |
| 75 | Urinary urgency (HP:0000012) | 2.43455079 |
| 76 | Peripheral hypomyelination (HP:0007182) | 2.41936512 |
| 77 | Hand muscle atrophy (HP:0009130) | 2.38941078 |
| 78 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.38543413 |
| 79 | Amblyopia (HP:0000646) | 2.37960270 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.34585830 |
| 81 | Dysmetria (HP:0001310) | 2.30605620 |
| 82 | Rigidity (HP:0002063) | 2.30354208 |
| 83 | Postural tremor (HP:0002174) | 2.25930647 |
| 84 | Increased circulating renin level (HP:0000848) | 2.25530559 |
| 85 | Spastic gait (HP:0002064) | 2.25332828 |
| 86 | Abnormality of the diencephalon (HP:0010662) | 2.24092415 |
| 87 | Abnormality of the lower motor neuron (HP:0002366) | 2.23383686 |
| 88 | Obstructive sleep apnea (HP:0002870) | 2.23263607 |
| 89 | Bradykinesia (HP:0002067) | 2.22194063 |
| 90 | Facial shape deformation (HP:0011334) | 2.22025766 |
| 91 | Potter facies (HP:0002009) | 2.22025766 |
| 92 | Decreased lacrimation (HP:0000633) | 2.22021102 |
| 93 | Absence seizures (HP:0002121) | 2.21574671 |
| 94 | Retinal dysplasia (HP:0007973) | 2.20698407 |
| 95 | Intention tremor (HP:0002080) | 2.18945201 |
| 96 | Dialeptic seizures (HP:0011146) | 2.18705292 |
| 97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17179326 |
| 98 | Ventricular fibrillation (HP:0001663) | 2.16826312 |
| 99 | Distal upper limb amyotrophy (HP:0007149) | 2.13664916 |
| 100 | Upper limb amyotrophy (HP:0009129) | 2.13664916 |
| 101 | Generalized tonic-clonic seizures (HP:0002069) | 2.13663045 |
| 102 | Anosmia (HP:0000458) | 2.13305388 |
| 103 | Gait imbalance (HP:0002141) | 2.12694525 |
| 104 | Hyperventilation (HP:0002883) | 2.11495549 |
| 105 | Dysmetric saccades (HP:0000641) | 2.10387781 |
| 106 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08605035 |
| 107 | Gaze-evoked nystagmus (HP:0000640) | 2.07706099 |
| 108 | Exotropia (HP:0000577) | 2.06066986 |
| 109 | Lower limb muscle weakness (HP:0007340) | 2.05782024 |
| 110 | Abnormality of dental color (HP:0011073) | 2.05453883 |
| 111 | Distal lower limb muscle weakness (HP:0009053) | 2.04311444 |
| 112 | Torticollis (HP:0000473) | 2.04256986 |
| 113 | Palpitations (HP:0001962) | 2.03353979 |
| 114 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.02355063 |
| 115 | Mutism (HP:0002300) | 2.02094892 |
| 116 | Abnormality of the parietal bone (HP:0002696) | 2.02042918 |
| 117 | Cerebral hemorrhage (HP:0001342) | 2.01363897 |
| 118 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.99170807 |
| 119 | Short 4th metacarpal (HP:0010044) | 1.99170807 |
| 120 | Episodic fever (HP:0001954) | 1.99086582 |
| 121 | Visual hallucinations (HP:0002367) | 1.98820123 |
| 122 | Peripheral demyelination (HP:0011096) | 1.97250873 |
| 123 | Hypomagnesemia (HP:0002917) | 1.96779618 |
| 124 | Upper limb muscle weakness (HP:0003484) | 1.96748609 |
| 125 | Epileptiform EEG discharges (HP:0011182) | 1.95690643 |
| 126 | Abnormal hair whorl (HP:0010721) | 1.95655430 |
| 127 | Chin dimple (HP:0010751) | 1.92064426 |
| 128 | Fetal akinesia sequence (HP:0001989) | 1.90677421 |
| 129 | Paraplegia (HP:0010550) | 1.90480335 |
| 130 | Insomnia (HP:0100785) | 1.88717054 |
| 131 | Epileptic encephalopathy (HP:0200134) | 1.86370733 |
| 132 | Hypoplasia of the iris (HP:0007676) | 1.85765602 |
| 133 | Truncal ataxia (HP:0002078) | 1.85573171 |
| 134 | Anhidrosis (HP:0000970) | 1.85008489 |
| 135 | Stereotypic behavior (HP:0000733) | 1.81756978 |
| 136 | Increased CSF protein (HP:0002922) | 1.79574391 |
| 137 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79314647 |
| 138 | Tetraplegia (HP:0002445) | 1.78633683 |
| 139 | Axonal loss (HP:0003447) | 1.78366502 |
| 140 | Mask-like facies (HP:0000298) | 1.78276423 |
| 141 | Genital tract atresia (HP:0001827) | 1.77685646 |
| 142 | Menstrual irregularities (HP:0000858) | 1.77129772 |
| 143 | Trigonocephaly (HP:0000243) | 1.76759258 |
| 144 | Abnormality of saccadic eye movements (HP:0000570) | 1.76535127 |
| 145 | Sensory axonal neuropathy (HP:0003390) | 1.75694053 |
| 146 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74112418 |
| 147 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.73609516 |
| 148 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.73609516 |
| 149 | Neuroblastoma (HP:0003006) | 1.73134527 |
| 150 | Primitive neuroectodermal tumor (HP:0030065) | 1.73134527 |
| 151 | Neuroblastic tumors (HP:0004376) | 1.73134527 |
| 152 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.73134527 |
| 153 | Cutaneous finger syndactyly (HP:0010554) | 1.71856926 |
| 154 | Spastic paraplegia (HP:0001258) | 1.71748883 |
| 155 | Abnormality of the 4th metacarpal (HP:0010012) | 1.71655969 |
| 156 | Rapidly progressive (HP:0003678) | 1.71336088 |
| 157 | Impaired vibratory sensation (HP:0002495) | 1.71208752 |
| 158 | Neoplasm of the thyroid gland (HP:0100031) | 1.69466439 |
| 159 | Prolonged QT interval (HP:0001657) | 1.67937498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 5.58288364 |
| 2 | NTRK3 | 3.73550417 |
| 3 | LMTK2 | 3.62300247 |
| 4 | MATK | 3.32646335 |
| 5 | KSR2 | 3.19331218 |
| 6 | NTRK2 | 3.17304565 |
| 7 | MINK1 | 3.07293135 |
| 8 | MAP4K2 | 3.06424631 |
| 9 | MAP3K2 | 2.92390032 |
| 10 | LIMK1 | 2.80190895 |
| 11 | MAP3K9 | 2.64788949 |
| 12 | GRK5 | 2.61282213 |
| 13 | RIPK4 | 2.59493347 |
| 14 | CASK | 2.27220613 |
| 15 | MAP3K12 | 2.17949266 |
| 16 | RIPK1 | 2.16579744 |
| 17 | EPHA4 | 2.02682464 |
| 18 | PHKG2 | 2.02071890 |
| 19 | PHKG1 | 2.02071890 |
| 20 | PNCK | 1.95647721 |
| 21 | RET | 1.94929153 |
| 22 | FGFR2 | 1.94704638 |
| 23 | ARAF | 1.88014627 |
| 24 | LATS2 | 1.85802704 |
| 25 | TYRO3 | 1.81289031 |
| 26 | CAMK2B | 1.78169425 |
| 27 | PKN1 | 1.78114885 |
| 28 | EPHA3 | 1.72341525 |
| 29 | MAP3K4 | 1.57280258 |
| 30 | MAPK15 | 1.54753267 |
| 31 | MAP2K7 | 1.53317509 |
| 32 | MARK3 | 1.49590458 |
| 33 | MAP2K4 | 1.42836725 |
| 34 | MAP2K1 | 1.41988837 |
| 35 | MAPK13 | 1.39147126 |
| 36 | MAPKAPK3 | 1.37258537 |
| 37 | MARK2 | 1.35817504 |
| 38 | GRK7 | 1.32883926 |
| 39 | STK39 | 1.31052934 |
| 40 | SGK223 | 1.28757994 |
| 41 | SGK494 | 1.28757994 |
| 42 | WNK1 | 1.28735772 |
| 43 | TNIK | 1.26114139 |
| 44 | TRIB3 | 1.24562997 |
| 45 | RPS6KA2 | 1.24307310 |
| 46 | SIK3 | 1.24029465 |
| 47 | PAK6 | 1.23642584 |
| 48 | ADRBK2 | 1.20938985 |
| 49 | SIK2 | 1.15166259 |
| 50 | FER | 1.11761195 |
| 51 | MAP3K1 | 1.10064943 |
| 52 | ADRBK1 | 1.08462195 |
| 53 | MAP2K2 | 1.06088704 |
| 54 | DDR2 | 1.05550644 |
| 55 | WNK4 | 0.99245802 |
| 56 | DAPK2 | 0.95596344 |
| 57 | PDK2 | 0.95309155 |
| 58 | PDGFRA | 0.94905026 |
| 59 | PRKCE | 0.93348758 |
| 60 | SGK1 | 0.93273221 |
| 61 | SGK2 | 0.93263338 |
| 62 | YES1 | 0.86900015 |
| 63 | CDK5 | 0.83785319 |
| 64 | PINK1 | 0.82512894 |
| 65 | CAMKK2 | 0.81959164 |
| 66 | NEK6 | 0.81589251 |
| 67 | PRKCG | 0.74791564 |
| 68 | UHMK1 | 0.74466750 |
| 69 | MARK1 | 0.73373363 |
| 70 | DYRK1A | 0.73359850 |
| 71 | PRKG2 | 0.72466121 |
| 72 | ICK | 0.69823928 |
| 73 | PRKD1 | 0.69117120 |
| 74 | DYRK2 | 0.68313126 |
| 75 | MAPK12 | 0.67963554 |
| 76 | BLK | 0.67888831 |
| 77 | BMPR1B | 0.65981827 |
| 78 | PKN2 | 0.63689493 |
| 79 | FES | 0.63158893 |
| 80 | CSNK1G1 | 0.62946094 |
| 81 | RPS6KA3 | 0.60716771 |
| 82 | CSNK1G2 | 0.60145967 |
| 83 | CDK14 | 0.59720156 |
| 84 | CAMK2A | 0.57680363 |
| 85 | CAMK1 | 0.57378261 |
| 86 | PDGFRB | 0.53329536 |
| 87 | EPHB1 | 0.51469803 |
| 88 | SGK3 | 0.51034683 |
| 89 | OXSR1 | 0.50530223 |
| 90 | MAP3K7 | 0.50311212 |
| 91 | PRKG1 | 0.49591258 |
| 92 | MET | 0.47563242 |
| 93 | CSNK1G3 | 0.47434947 |
| 94 | BRAF | 0.47034464 |
| 95 | SCYL2 | 0.46118610 |
| 96 | IRAK1 | 0.45961411 |
| 97 | FYN | 0.45938492 |
| 98 | CDK15 | 0.45153468 |
| 99 | CSNK1A1 | 0.44667791 |
| 100 | ERBB2 | 0.44443536 |
| 101 | TRPM7 | 0.43990502 |
| 102 | CAMK2G | 0.43863949 |
| 103 | CAMK2D | 0.43186053 |
| 104 | STK24 | 0.42140268 |
| 105 | PRKACA | 0.41900458 |
| 106 | IRAK2 | 0.40695331 |
| 107 | CDC42BPA | 0.39765741 |
| 108 | PRKAA1 | 0.39686057 |
| 109 | ROCK2 | 0.39195745 |
| 110 | STK38 | 0.38694529 |
| 111 | MUSK | 0.38186320 |
| 112 | PTK2 | 0.37974316 |
| 113 | CDK11A | 0.37726515 |
| 114 | CAMKK1 | 0.37392671 |
| 115 | ACVR1B | 0.37264396 |
| 116 | PRKCZ | 0.37047509 |
| 117 | PDK1 | 0.36822599 |
| 118 | PAK3 | 0.36735001 |
| 119 | PIM2 | 0.36114306 |
| 120 | ALK | 0.35447710 |
| 121 | PDPK1 | 0.35206868 |
| 122 | STK11 | 0.34713726 |
| 123 | PTK2B | 0.34136621 |
| 124 | MAP2K6 | 0.34034481 |
| 125 | ROCK1 | 0.33836107 |
| 126 | BMX | 0.33013152 |
| 127 | MAPK4 | 0.32890068 |
| 128 | MAPK7 | 0.32100125 |
| 129 | GSK3B | 0.31980653 |
| 130 | FGFR3 | 0.31523300 |
| 131 | CSNK1D | 0.31153973 |
| 132 | CSNK1A1L | 0.29451172 |
| 133 | MAPKAPK5 | 0.27625902 |
| 134 | BCR | 0.27504646 |
| 135 | PLK2 | 0.27239891 |
| 136 | SRC | 0.26339281 |
| 137 | PRKACB | 0.25701345 |
| 138 | CDK18 | 0.24471229 |
| 139 | CSNK1E | 0.24323545 |
| 140 | PRKD3 | 0.23404736 |
| 141 | MYLK | 0.22912307 |
| 142 | PRKACG | 0.22697395 |
| 143 | MAPK10 | 0.22402337 |
| 144 | TNK2 | 0.21199616 |
| 145 | TESK1 | 0.20758141 |
| 146 | PRKCA | 0.19996035 |
| 147 | PRKCH | 0.19770585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26832921 |
| 2 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.19189951 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.08405564 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50323804 |
| 5 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 2.20115735 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 2.11160086 |
| 7 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.07644870 |
| 8 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.95853728 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.94371499 |
| 10 | Thyroid cancer_Homo sapiens_hsa05216 | 1.90200950 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87620608 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84719250 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.81413552 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80805828 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.65381657 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64357064 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62724786 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.58643824 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56096244 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55026705 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.47203076 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47062558 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46559325 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.45515219 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43971499 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.43951476 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32397450 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32260059 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.31763939 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27636176 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23909979 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.22664602 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20790466 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20759103 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16661208 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.16598939 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15143883 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14847661 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.14690573 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14368881 |
| 41 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.13693211 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12725947 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.10014035 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09814846 |
| 45 | Melanoma_Homo sapiens_hsa05218 | 1.08575147 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.08391449 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.05831722 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04824894 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01712991 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.00304217 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98131111 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.98012591 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97290149 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96771390 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.95854116 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.95619293 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94414082 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94307092 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93972299 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93668202 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.92325200 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.91248674 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90005297 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89138696 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88820275 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88350234 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86416506 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85809998 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83625784 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82927769 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82352995 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80960655 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80678968 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80298889 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75837209 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74672913 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73579582 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73508654 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71557215 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71349076 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71090332 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70463758 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.69840462 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69448239 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.69427113 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.69286765 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68085943 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67386583 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67233426 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66649612 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63463484 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62505097 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62134559 |
| 94 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61820465 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61007468 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60314265 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.60157968 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59877503 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59567982 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58908320 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57577361 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56987184 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.56311096 |
| 104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54808055 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54451740 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53437935 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53111469 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52703303 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52639465 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52382501 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52266830 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52151662 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51340880 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49908986 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48108842 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46416186 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44964806 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.44813127 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44723140 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43868732 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.42415355 |
| 122 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42147499 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42068137 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41771918 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41410136 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40722721 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39628874 |
| 128 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33490713 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33006727 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31696102 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.31526664 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.31320714 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.30465950 |
| 134 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30105579 |

